Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999631 | Urologic Oncology: Seminars and Original Investigations | 2015 | 6 Pages |
Abstract
Our study suggests discordant oncologic outcomes and prognostic factors between metastatic UTUC and UCB after cisplatin-based chemotherapy. A prospective study is warranted to validate our results.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Meng-Che M.D., Po-Hui M.D., Ph.D., Kun-Ming M.D., Yen-Yang M.D., Yu-Li M.D., Cheng-Hua M.D.,